Financhill
Back

Altamira Therapeutics Stock Predictions

Altamira Therapeutics Stock Forecast

  • Is Altamira Therapeutics Stock Undervalued?
    The current Altamira Therapeutics [CYTOF] share price is $0.12. The Score for CYTOF is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • CYTOF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Altamira Therapeutics Stock Go Up Next Year?

Data Unavailable

Altamira Therapeutics Stock Rating

Data Unavailable

Altamira Therapeutics Stock Price History

Is CYTOF stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYTOF is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
OTCM
Country:
Bermuda
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
altamiratherapeutics.com

52-Week Data

52-Week High:
3.60
52-Week Low:
0.10

Prediction Charts

Market Cap:
452.7K
Price in USD:
0.12
Volume:
745.1K
Beta:
1.65

Technical Analysis

SMA50:
0.47
SMA100:
0.66
SMA200:
1.09
52-Wk Change:
-95.56%

Stock Predictions

  • Is Altamira Therapeutics stock public?
    Yes, Altamira Therapeutics is a publicly traded company.
  • What is the Altamira Therapeutics stock quote today?
    The Altamira Therapeutics stock price is 0.12 USD today.
  • How to buy Altamira Therapeutics stock online?
    You can buy Altamira Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-3 0.42 0.48 0.54 0.42
Dec-4 0.49 0.46 0.55 0.45
Dec-5 0.46 0.49 0.52 0.45
Dec-6 0.48 0.52 0.53 0.47
Dec-9 0.52 0.49 0.58 0.45
Dec-10 0.47 0.46 0.50 0.44
Dec-11 0.46 0.47 0.49 0.43
Dec-12 0.45 0.46 0.46 0.43
Dec-13 0.44 0.43 0.46 0.43
Dec-16 0.43 0.42 0.45 0.42
Dec-17 0.41 0.41 0.44 0.40
Dec-18 0.42 0.41 0.43 0.40
Dec-19 0.42 0.30 0.43 0.30
Dec-20 0.14 0.12 0.20 0.10

Altamira Therapeutics Earnings

Data Unavailable

Altamira Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $1.76 per share.

* Altamira Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.